• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017.中东和北非地区肝细胞癌日益增长的威胁：2017年全球疾病负担研究结果
Clin Liver Dis (Hoboken). 2020 Jan 29;14(6):219-223. doi: 10.1002/cld.890. eCollection 2019 Dec.
2
Osteoporosis strategic plan for the Middle East and North Africa region.中东和北非地区骨质疏松症战略计划。
Arch Osteoporos. 2019 Feb 14;14(1):20. doi: 10.1007/s11657-019-0567-4.
3
Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region.多发性硬化症与人类白细胞抗原基因型：聚焦中东和北非地区
Mult Scler J Exp Transl Clin. 2020 Jan 9;6(1):2055217319881775. doi: 10.1177/2055217319881775. eCollection 2020 Jan-Mar.
4
Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.中东和北非地区成年人的哮喘控制情况：ESMAA 研究结果。
Respir Med. 2018 May;138:64-73. doi: 10.1016/j.rmed.2018.03.024. Epub 2018 Mar 26.
5
Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010.中东和北非地区胃肠道及肝脏疾病负担：1990年至2010年全球疾病负担研究结果
Middle East J Dig Dis. 2015 Oct;7(4):201-15.
6
Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.扩展的中东和北非地区人乳头瘤病毒感染及相关疾病的负担。
Vaccine. 2013 Dec 30;31 Suppl 6:G32-44. doi: 10.1016/j.vaccine.2012.06.098.
7
Dietary trends in the Middle East and North Africa: an ecological study (1961 to 2007).中东和北非的饮食趋势：一项生态学研究（1961 年至 2007 年）。
Public Health Nutr. 2012 Oct;15(10):1835-44. doi: 10.1017/S1368980011003673. Epub 2012 Feb 9.
8
Regional status and approaches to control and eradication of foot and mouth disease in the Middle East and North Africa.中东和北非口蹄疫的区域状况及防控与根除方法
Rev Sci Tech. 2002 Dec;21(3):451-8. doi: 10.20506/rst.21.3.1348.
9
Global differences in lung function by region (PURE): an international, community-based prospective study.按地区划分的全球肺功能差异（纯粹研究）：一项国际社区为基础的前瞻性研究。
Lancet Respir Med. 2013 Oct;1(8):599-609. doi: 10.1016/S2213-2600(13)70164-4. Epub 2013 Sep 10.
10
Estimating HCV disease burden-volume 4 (editorial).估算丙型肝炎病毒疾病负担——第4卷（社论）
J Viral Hepat. 2017 Oct;24 Suppl 2:4-7. doi: 10.1111/jvh.12763.

引用本文的文献

1
Representation of the Middle East and North African Region in Oncology Clinical Trials.中东和北非地区在肿瘤学临床试验中的代表性。
JAMA Oncol. 2025 Jun 1;11(6):668-670. doi: 10.1001/jamaoncol.2025.0764.
2
Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma.北非的丙型肝炎：流行病学、基因多样性和肝细胞癌的综合综述
Adv Virol. 2025 Mar 24;2025:9927410. doi: 10.1155/av/9927410. eCollection 2025.
3
Liver Cancer and Risk Factors in the MENA Region: Epidemiology and Temporal Trends Based on the 2019 Global Burden of Disease Data.中东和北非地区的肝癌与风险因素：基于 2019 年全球疾病负担数据的流行病学和时间趋势。
Cancer Control. 2024 Jan-Dec;31:10732748241297346. doi: 10.1177/10732748241297346.
4
Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.肝硬化患者不确定肝脏结节恶性肿瘤风险：一项回顾性队列研究。
J Gastrointest Cancer. 2024 Oct 16;56(1):1. doi: 10.1007/s12029-024-01122-7.
5
Development of a flexible liver phantom for hepatocellular carcinoma treatment planning: a useful tool for training & education.用于肝细胞癌治疗规划的柔性肝脏体模的开发：培训与教育的有用工具。
3D Print Med. 2024 Jul 22;10(1):24. doi: 10.1186/s41205-024-00228-9.
6
Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery.卡瑞利珠单抗联合仑伐替尼用于肝细胞癌术后辅助治疗的临床疗效及安全性评估
Front Oncol. 2023 Dec 13;13:1174999. doi: 10.3389/fonc.2023.1174999. eCollection 2023.
7
Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and Recommendations.海湾地区肝细胞癌的管理现状：挑战与建议
Cancers (Basel). 2023 Mar 28;15(7):2001. doi: 10.3390/cancers15072001.
8
Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1.源自过表达微小RNA-27a-3p的间充质干细胞的外泌体通过抑制高尔基体膜蛋白1来抑制肝癌进展。
Stem Cells Int. 2022 Dec 7;2022:9748714. doi: 10.1155/2022/9748714. eCollection 2022.
9
Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis.数字营销：一种消除病毒性肝炎的独特多学科方法。
Pathogens. 2022 May 29;11(6):626. doi: 10.3390/pathogens11060626.
10
Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.新型姜黄属植物提取物及化合物在肝癌中抗癌活性的最新进展
J Gastrointest Cancer. 2023 Jun;54(2):368-390. doi: 10.1007/s12029-022-00809-z. Epub 2022 Mar 14.

本文引用的文献

1
An overview of the Hepatitis C control plan in Qatar.卡塔尔丙型肝炎控制计划概述。
East Mediterr Health J. 2019 Jul 24;25(5):362-365. doi: 10.26719/emhj.18.046.
2
Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.在实际监狱环境中，一种快速诊断检测用于筛查丙型肝炎的性能。
J Clin Virol. 2019 Apr;113:20-23. doi: 10.1016/j.jcv.2019.02.005. Epub 2019 Feb 25.
3
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.迈向丙型肝炎病毒消除：埃及的经验、成就和局限。
World J Gastroenterol. 2018 Oct 14;24(38):4330-4340. doi: 10.3748/wjg.v24.i38.4330.
4
Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?晚期肝细胞癌的长期缓解？治愈的机会？
Memo. 2018;11(3):185-192. doi: 10.1007/s12254-018-0431-z. Epub 2018 Aug 24.
5
One step closer to elimination of hepatitis C in Egypt.埃及在消除丙型肝炎方面又迈进了一步。
Lancet Gastroenterol Hepatol. 2018 Oct;3(10):665. doi: 10.1016/S2468-1253(18)30268-1.
6
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.经动脉化疗栓塞术可延长不可切除肝细胞癌患者的长期生存期。
Medicine (Baltimore). 2018 Aug;97(33):e11872. doi: 10.1097/MD.0000000000011872.
7
Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study.替诺福韦治疗慢性乙型肝炎的肝硬化和非肝硬化患者中肝细胞癌发生率降低：一项倾向评分匹配研究。
J Infect Dis. 2019 Jan 1;219(1):10-18. doi: 10.1093/infdis/jiy391.
8
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.非酒精性脂肪性肝炎是肝移植候选者中肝细胞癌增长最快的病因。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.
9
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数，1990 年至 2016 年：全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.
10
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.2016 年全球乙型肝炎病毒感染的流行率、治疗和预防：一项建模研究。
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6. Epub 2018 Mar 27.

The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017.

作者信息

Sharafi Heidar, Alavian Seyed Moayed

机构信息

Middle East Liver Diseases Center Tehran Iran.

出版信息

Clin Liver Dis (Hoboken). 2020 Jan 29;14(6):219-223. doi: 10.1002/cld.890. eCollection 2019 Dec.

DOI:10.1002/cld.890
PMID:32015873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6988434/
Abstract
摘要